Search
The Institute of Medical Sciences

Dr Ian Fleming

In this section
Dr Ian Fleming
Dr Ian Fleming
Dr Ian Fleming

Senior Lecturer

About
Email Address
i.n.fleming@abdn.ac.uk
Telephone Number
+44 (0)1224 438357
Office Address

Aberdeen Biomedical Imaging Centre, Office 6.16, Institute of Medical Research, Foresterhill, Aberdeen AB25 2ZD, UK

School/Department
School of Medicine, Medical Sciences and Nutrition
Google Scholar
Linkedin
Research

Research Overview

Development of novel Positron Emission Tomography (PET) radiotracers to study the biological processes that are characteristic of tumour cells.

Development, validation and/or qualification of existing PET radiotracers so that they can be used as predictive, prognostic, pharmacological and/or surrogate response biomarkers in oncology patients.

Current Research

Current projects involve tracers to study cell proliferation, hypoxia and angiogenesis. 

Collaborations

Prof Fiona Gilbert, University of Cambridge

Prof Paula Ghaneh, University of Liverpool

Prof David O'Hagan, University of St Andrews

Kemotech, Italy

 

  

Funding and Grants

Current Grants:

Validation of FLT-PET as a predictive biomarker in breast cancer (Cancer Research UK)

18F-fluoroazomycin-arabinofuranoside (FAZA) as a PET tracer in the detection of tumour hypoxia in patients with colorectal carcinoma: A pilot study (NHS Grampian Endowment)

Detection of hypoxia in breast cancer with Fluoroazomycin arabinoside (FAZA) analogues (Breast Cancer Campaign)

Studying the effect of different hypoxic subtypes on anti-cancer therapeutics in breast cancer cells (NHS Grampian Endowment)   

Developing a novel αvβ3 radiotracer to report on tumour angiogenesis (Knowledge Exchange Transfer Fund)

Development of 18F-labelled PET tracer for preclinical HER2 imaging of gastroesophageal adenocarcinomas (NHS Grampian Endowment)  

Teaching

Teaching Responsibilities

Programme coordinator & lecturer BT3006: Working Out? Placement & Career skills

Programme coordinator BT5007: Industrial Placement/MSci course

Course coordinator & lecturer PA3802: Principles of Chemotherapy and mechanisms of disease

Course coordinator & lecturer BP5003: Biomedical and other Professional Topics

Lecturer SM2501: Research skills for Medical Sciences

Coordinator of Hotstart programme   

Publications

Page 4 of 6 Results 31 to 40 of 53

  • Hypoxia imaging with PET: which tracers and why?

    Chia, K., Fleming, I. N., Blower, P. J.
    Nuclear Medicine Communications, vol. 33, no. 3, pp. 217-222
    Contributions to Journals: Editorials

  • Building PET research collaborations

    Fleming, I. N., Gilbert, F. J., Blower, P. J.
    Nuclear Medicine Communications, vol. 33, no. 1, pp. 1-3
    Contributions to Journals: Articles

  • Linear Trifluoroethylamine RGD Peptidomimetics: Stereoselective Synthesis and Integrin alphavbeta3 affinity

    Piras, M., Fleming, I. N., Harrison, W. T. A., Zanda, M.
    Synlett, vol. 23, no. 20, pp. 2899-2902
    Contributions to Journals: Articles

  • Beyond 18F-fluorodeoxyglucose: making the next generation of PET radiotracers available for oncology research in the UK

    Gilbert, F. J., Fleming, I. N., Marsden, P. K.
    Nuclear Medicine Communications, vol. 32, no. 1, pp. 1-3
    Contributions to Journals: Editorials

  • Combination of sapacitabine and HDAC inhibitors stimulates cell death in AML and other tumour types

    Green, S. R., Choudhary, A. K., Fleming, I. N.
    British Journal of Cancer, vol. 103, no. 9, pp. 1391-1399
    Contributions to Journals: Articles

  • Opportunities for PET to deliver clinical benefit in cancer: breast cancer as a paradigm

    Fleming, I. N., Gilbert, F. J., Miles, K. A., Cameron, D.
    Cancer Imaging, vol. 10, no. 1, pp. 144-152
    Contributions to Journals: Articles

  • Synergistic inhibition of ErbB signaling by combined treatment with seliciclib and ErbB-targeting agents

    Fleming, I. N., Hogben, M., Frame, S., McClue, S. J., Green, S. R.
    Clinical Cancer Research, vol. 14, no. 13, pp. 4326-4335
    Contributions to Journals: Articles

  • The regulation of membrane to cytosol partitioning of signalling proteins by phosphoinositides and their soluble headgroups

    Downes, C. P., Gray, A., Fairservice, A., Safrany, S. T., Batty, I. H., Fleming, I. N.
    Biochemical Society Transactions, vol. 33, no. Pt 6, pp. 1303-1307
    Contributions to Journals: Articles

  • Inositol phospholipids regulate the guanine-nucleotide-exchange factor Tiam1 by facilitating its binding to the plasma membrane and regulating GDP/GTP exchange on Rac1

    Fleming, I. N., Batty, I. H., Prescott, A. R., Gray, A., Kular, G. S., Stewart, H., Downes, C. P.
    Biochemical Journal, vol. 382, no. 3, pp. 857-865
    Contributions to Journals: Articles

  • Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells

    Batty, I. H., Fleming, I. N., Downes, C. P.
    Biochemical Journal, vol. 379, no. 3, pp. 641-651
    Contributions to Journals: Articles
Show 10 | 25 | 50 | 100 results per page

Refine

Contributions to Journals

Contributions to Specialist Publications

Update